Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
- PMID: 30326299
- DOI: 10.1016/j.cgh.2018.10.017
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Abstract
Background & aims: Bariatric surgery has been reported to lead to complete resolution of nonalcoholic fatty liver disease (NAFLD) following the sustained weight loss induced in obese patients. We performed a systematic review and meta-analysis to evaluate the effects of bariatric surgery on NAFLD in obese patients.
Methods: We searched MEDLINE, EMBASE, CENTRAL, and Web of Science databases through May 2018 for studies that compared liver biopsy results before and after bariatric surgery in obese patients. Primary outcomes were biopsy-confirmed resolution of NAFLD and NAFLD activity score. Secondary outcomes were worsening of NAFLD after surgery and liver volume. The Grading of Recommendations, Assessment, Development, and Evidence approach was conducted to assess overall quality of evidence.
Results: We analyzed data from 32 cohort studies comprising 3093 biopsy specimens. Bariatric surgery resulted in a biopsy-confirmed resolution of steatosis in 66% of patients (95% CI, 56%-75%), inflammation in 50% (95% CI, 35%-64%), ballooning degeneration in 76% (95% CI, 64%-86%), and fibrosis in 40% (95% CI, 29%-51%). Patients' mean NAFLD activity score was reduced significantly after bariatric surgery (mean difference, 2.39; 95% CI, 1.58-3.20; P < .001). However, bariatric surgery resulted in new or worsening features of NAFLD, such as fibrosis, in 12% of patients (95% CI, 5%-20%). The overall Grading of Recommendations, Assessment, Development, and Evidence quality of evidence was very low.
Conclusions: Through this systematic review and meta-analysis, we found that bariatric surgery leads to complete resolution of NAFLD in obese patients. However, some patients develop new or worsened features of NAFLD. Randomized controlled trials are needed to further examine the therapeutic benefits of bariatric surgery for patients with NAFLD.
Keywords: Hepatic Histology; Metabolic Surgery; Morbid Obesity; NASH.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
Do We Need a Randomized Controlled Trial on This Issue? Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery.Clin Gastroenterol Hepatol. 2019 Apr;17(5):1006. doi: 10.1016/j.cgh.2018.11.007. Clin Gastroenterol Hepatol. 2019. PMID: 30902229 No abstract available.
-
Reply.Clin Gastroenterol Hepatol. 2019 Apr;17(5):1007. doi: 10.1016/j.cgh.2018.11.021. Clin Gastroenterol Hepatol. 2019. PMID: 30902231 No abstract available.
Similar articles
-
Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.Obes Surg. 2022 Jun;32(6):1872-1883. doi: 10.1007/s11695-022-06011-1. Epub 2022 Apr 6. Obes Surg. 2022. PMID: 35386040
-
Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2022 Mar;20(3):511-524.e1. doi: 10.1016/j.cgh.2021.03.017. Epub 2021 Mar 13. Clin Gastroenterol Hepatol. 2022. PMID: 33727164
-
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6. doi: 10.1053/j.gastro.2015.04.014. Epub 2015 Apr 25. Gastroenterology. 2015. PMID: 25917783
-
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.Obes Surg. 2015 Dec;25(12):2280-9. doi: 10.1007/s11695-015-1691-x. Obes Surg. 2015. PMID: 25917981 Review.
-
Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis.World J Surg. 2022 May;46(5):1122-1133. doi: 10.1007/s00268-021-06382-z. Epub 2022 Mar 11. World J Surg. 2022. PMID: 35275232 Review.
Cited by
-
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?Int J Mol Sci. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375. Int J Mol Sci. 2021. PMID: 34065331 Free PMC article. Review.
-
Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD.Obes Surg. 2023 May;33(5):1494-1505. doi: 10.1007/s11695-023-06490-w. Epub 2023 Mar 7. Obes Surg. 2023. PMID: 36881347 Free PMC article.
-
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction.JACC Basic Transl Sci. 2021 Nov 22;6(11):918-932. doi: 10.1016/j.jacbts.2021.07.010. eCollection 2021 Nov. JACC Basic Transl Sci. 2021. PMID: 34869957 Free PMC article. Review.
-
Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.J Clin Med. 2021 Dec 7;10(24):5721. doi: 10.3390/jcm10245721. J Clin Med. 2021. PMID: 34945016 Free PMC article. Review.
-
CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):9-12. doi: 10.1002/cld.1226. eCollection 2022 Jul. Clin Liver Dis (Hoboken). 2022. PMID: 35899239 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical